---
title: "Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237193540.md"
description: "Fuan Pharmaceutical released its Q1 2025 performance, with operating revenue of 468 million yuan, a year-on-year decrease of 42.22%; net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%; net profit after deducting non-recurring gains and losses of 65.6848 million yuan, a year-on-year decrease of 43.80%; basic earnings per share of 0.06 yuan/share"
datetime: "2025-04-23T13:28:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237193540.md)
  - [en](https://longbridge.com/en/news/237193540.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237193540.md)
generator: "portal-rs"
---

# Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%

According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) released its first-quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 468 million yuan, a year-on-year decrease of 42.22%; the net profit attributable to shareholders of the listed company was 69.049 million yuan, a year-on-year decrease of 43.63%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 65.6848 million yuan, a year-on-year decrease of 43.80%; the basic earnings per share was 0.06 yuan/share

### Related Stocks

- [300194.CN](https://longbridge.com/en/quote/300194.CN.md)

## Related News & Research

- [Chinese Pharma Companies Plan Hong Kong Listings](https://longbridge.com/en/news/297979501.md)
- [Grace Therapeutics CEO presents at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297910585.md)
- [Growexa Launches Lender-Ready Business Plan Platform to Bridge Small Business Lending Gap](https://longbridge.com/en/news/297990726.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [15:12 ETTGI Fridays™ Signs Landmark Development Agreement with Devolli Group, Accelerating Global Growth with First-Ever Expansion into the Balkans](https://longbridge.com/en/news/298068531.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**